Solid Lipid Nanoparticles: A Modern Formulation Approach in Drug Delivery System

被引:580
作者
Mukherjee, S. [1 ]
Ray, S. [1 ]
Thakur, R. S. [1 ]
机构
[1] Krupanidhi Coll Pharm, Dept Pharmaceut, Bangalore 560034, Karnataka, India
关键词
Solid lipid nanoparticles (SLN); colloidal drug carriers; homogenization; TEM; PCS; biodistribution; targeting; OCCLUSIVE PROPERTIES; BODY DISTRIBUTION; TOPICAL DELIVERY; BREAST-CANCER; GENE DELIVERY; CARRIERS NLC; SLN; RELEASE; LIPOSPHERES; DOXORUBICIN;
D O I
10.4103/0250-474X.57282
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Solid lipid nanoparticles are at the forefront of the rapidly developing field of nanotechnology with several potential applications in drug delivery, clinical medicine and research, as well as in other varied sciences. Due to their unique size-dependent properties, lipid nanoparticles offer the possibility to develop new therapeutics. The ability to incorporate drugs into nanocarriers offers a new prototype in drug delivery that could be used for secondary and tertiary levels of drug targeting. Hence, solid lipid nanoparticles hold great promise for reaching the goal of controlled and site specific drug delivery and hence have attracted wide attention of researchers. This review presents a broad treatment of solid lipid nanoparticles discussing their advantages, limitations and their possible remedies. The different types of nanocarriers which were based on solid lipid like solid lipid nanoparticles, nanostructured lipid carriers, lipid drug conjugates are discussed with their structural differences. Different production methods which are suitable for large scale production and applications of solid lipid nanoparticles are described. Appropriate analytical techniques for characterization of solid lipid nanoparticles like photon correlation spectroscopy, scanning electron microscopy, differential scanning calorimetry are highlighted. Aspects of solid lipid nanoparticles route of administration and their biodistribution are also incorporated. If appropriately investigated, solid lipid nanoparticles may open new vistas in therapy of complex diseases.
引用
收藏
页码:349 / 358
页数:10
相关论文
共 61 条
[1]  
Ahlin P., 1998, ACTA PHARM, V48, P257
[2]  
BOLTRI L, 1993, P INT S CONTR REL BI, V20, P346
[3]   SOLID LIPOSPHERES OF DOXORUBICIN AND IDARUBICIN [J].
CAVALLI, R ;
CAPUTO, O ;
GASCO, MR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 89 (01) :R9-R12
[4]  
Cavalli R, 1996, EUR J PHARM BIOPHARM, V42, P110
[5]   Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting [J].
Chen, HB ;
Chang, XL ;
Du, DR ;
Liu, W ;
Liu, J ;
Weng, T ;
Yang, YJ ;
Xu, HB ;
Yang, XL .
JOURNAL OF CONTROLLED RELEASE, 2006, 110 (02) :296-306
[6]  
Chen Yan-jun, 2006, Zhongguo Zhong Yao Za Zhi, V31, P376
[7]  
Choi Myeong Jun, 2006, Current Drug Delivery, V3, P37, DOI 10.2174/156720106775197484
[8]   Production of lipospheres as carriers for bioactive compounds [J].
Cortesi, R ;
Esposito, E ;
Luca, G ;
Nastruzzi, C .
BIOMATERIALS, 2002, 23 (11) :2283-2294
[9]   APPLICATION OF AN ORIGINAL PROCESS FOR OBTAINING COLLOIDAL DISPERSIONS OF SOME COATING POLYMERS - PREPARATION, CHARACTERIZATION, INDUSTRIAL SCALE-UP [J].
DELABOURET, A ;
THIOUNE, O ;
FESSI, H ;
DEVISSAGUET, JP ;
PUISIEUX, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (02) :229-241
[10]   IMAGING CRYSTALS, POLYMERS, AND PROCESSES IN WATER WITH THE ATOMIC FORCE MICROSCOPE [J].
DRAKE, B ;
PRATER, CB ;
WEISENHORN, AL ;
GOULD, SAC ;
ALBRECHT, TR ;
QUATE, CF ;
CANNELL, DS ;
HANSMA, HG ;
HANSMA, PK .
SCIENCE, 1989, 243 (4898) :1586-1589